Can a Pancoast tumor be benign?
Other malignancies either primary adenoid cystic carcinomas, hemangiopericytomas, thyroid carcinomas, lymphomas, plasmacytomas or metastasis from any primary carcinoma, or even benign tumors occupying the superior pulmonary sulcus are known to cause Pancoast syndrome.
When should I worry about shoulder blade pain?
Any back or shoulder pain that lingers a few weeks or interferes with daily activities should be evaluated by a doctor. If your pain is severe or accompanied by other red flag symptoms—such as headache, tingling, weakness, or nausea—seek immediate medical attention.
Is Pancoast tumor shoulder pain constant?
Pancoast Tumor Symptoms
The associated pain is severe and constant, often requiring narcotic pain medications for relief. The affected person usually needs to support the elbow of the affected arm in the opposite hand to ease the tension on the shoulder and upper arm.
Where does Pancoast tumor spread to?
A Pancoast tumour can spread into one or more structures in the top part of the chest, which include: the top ribs in the chest (the thoracic ribs) nerves in the top of the chest. bundles of nerves close to the spinal cord that supply the arm and hand (the brachial plexus)
Can an MRI detect Pancoast tumor?
In a study of 31 patients with Pancoast tumors, MRI had a sensitivity of 88%, a specificity of 100%, and an overall accuracy of 94%. (See the images below.) Pancoast tumor. Sagittal fast spin-echo T2-weighted MRI shows collapsed vertebrae and cord compression at C7, T1, and T2 caused by a soft tissue mass.
What syndrome is associated with Pancoast tumor?
A Pancoast tumor can give rise to both Pancoast syndrome and Horner’s syndrome. When the brachial plexus roots are involved, it will produce Pancoast syndrome; involvement of sympathetic fibers as they exit the cord at T1 and ascend to the superior cervical ganglion will produce Horner’s syndrome.
What is the prognosis of Pancoast tumor?
For patients with early-stage, surgically-treatable cancer, the five-year survival rate is generally considered to be between 30 and 50 percent, although rates as high as 90 percent have been more reported in patient groups with very favorable characteristics.